Oppenheimer & Co. Inc. Sells 4,056 Shares of Crocs, Inc. (NASDAQ:CROX)

Oppenheimer & Co. Inc. decreased its position in Crocs, Inc. (NASDAQ:CROX) by 27.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,650 shares of the textile maker’s stock after selling 4,056 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Crocs were worth $1,554,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. V Square Quantitative Management LLC bought a new position in Crocs in the first quarter worth $25,000. Rise Advisors LLC bought a new position in Crocs in the first quarter worth $25,000. Quest Partners LLC bought a new position in Crocs in the fourth quarter worth $53,000. Blue Trust Inc. increased its holdings in shares of Crocs by 19.3% during the second quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock valued at $144,000 after acquiring an additional 162 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Crocs by 8.9% during the second quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock valued at $152,000 after acquiring an additional 85 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.

Crocs Trading Up 2.2 %

Shares of NASDAQ:CROX opened at $138.43 on Wednesday. The stock has a market capitalization of $8.40 billion, a price-to-earnings ratio of 10.71, a PEG ratio of 1.29 and a beta of 2.00. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.95 and a current ratio of 1.50. The stock’s 50-day simple moving average is $134.55 and its two-hundred day simple moving average is $137.49. Crocs, Inc. has a 52-week low of $74.00 and a 52-week high of $165.32.

Crocs (NASDAQ:CROX) last announced its earnings results on Thursday, August 1st. The textile maker reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.59 by $0.42. The business had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Crocs had a return on equity of 53.20% and a net margin of 20.02%. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $3.59 earnings per share. Analysts expect that Crocs, Inc. will post 12.85 EPS for the current year.

Insiders Place Their Bets

In related news, Director John B. Replogle acquired 1,996 shares of the stock in a transaction dated Friday, August 2nd. The shares were purchased at an average cost of $123.96 per share, with a total value of $247,424.16. Following the transaction, the director now directly owns 7,064 shares in the company, valued at $875,653.44. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Douglas J. Treff sold 10,594 shares of Crocs stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the transaction, the director now directly owns 81,254 shares of the company’s stock, valued at approximately $10,756,404.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John B. Replogle acquired 1,996 shares of the stock in a transaction dated Friday, August 2nd. The shares were bought at an average cost of $123.96 per share, for a total transaction of $247,424.16. Following the completion of the transaction, the director now owns 7,064 shares in the company, valued at $875,653.44. The disclosure for this purchase can be found here. Insiders own 2.72% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CROX shares. Barclays reduced their price target on Crocs from $169.00 to $164.00 and set an “overweight” rating for the company in a report on Friday, August 2nd. UBS Group reduced their price target on Crocs from $148.00 to $146.00 and set a “neutral” rating for the company in a report on Tuesday, July 16th. Bank of America raised their price target on Crocs from $160.00 to $187.00 and gave the company a “buy” rating in a report on Thursday, June 20th. Raymond James downgraded Crocs from a “strong-buy” rating to an “outperform” rating and set a $164.00 price target for the company. in a report on Friday, August 2nd. Finally, StockNews.com upgraded Crocs from a “hold” rating to a “buy” rating in a report on Friday, August 23rd. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, Crocs currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.27.

Crocs Company Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.